Login / Signup

Weight loss after initiating anti-obesity medications and gout among overweight and obesity individuals: a population-based cohort study.

Yuqing ZhangYilun WangNicola DalbethJunqing XieJing WuChao ZengGuang-Hua LeiYuqing Zhang
Published in: Arthritis & rheumatology (Hoboken, N.J.) (2024)
A higher rate of weight loss after initiating orlistat within 1-year was associated with lower risks of incident gout and lower rates of recurrent gout flares among overweight or obese people.
Keyphrases
  • weight loss
  • uric acid
  • bariatric surgery
  • roux en y gastric bypass
  • gastric bypass
  • metabolic syndrome
  • weight gain
  • glycemic control
  • cardiovascular disease
  • type diabetes
  • risk assessment